BICLUSTER_ID : UPREG-24
PATHOGENS /3/ : pseudomonas aeruginosa,listeria monocytogenes,escherichia coli
TARGETS /21/ : SMOX, CCL20, PDE4B, PLAT, TNFRSF1B, SERPINB2, CASP7, GCH1, SAT1, TXNRD1, CXCL10, NFKB1, ENPEP, JAK2, IL6, IL1B, PTGS2, CASP1, IL8, TLR2, PLAUR
Gene SetLeading Edge Genes
NETPATH TNF ALPHA PATHWAY UPG0S2, TP53BP2, IFIT5, BTG3, PMAIP1, NFKBIA, GCH1, INHBA, CXCL2, SOD2, CXCL10, CFLAR, NFKB1, TNIP1, CXCL1, JUNB, BCL2A1, TNFAIP8, SERPINB9, WTAP, TNFAIP3, IL15RA, BID, NFKBIB, SMOX, ISGF3G, TNFRSF1B, CASP7, CLIC4, CXCL3, PTX3, IER3, CD69, PPP1R15A, TRIM21, ETS2, SLCO3A1, IL6, PTGS2, IL8, DUSP1, PLAUR
NETPATH IL 2 PATHWAY UPPFKFB3, IL18RAP, BTG3, LYN, NMI, PMAIP1, IFI44, CFLAR, NFKB1, IFIT1, B4GALT5, SP100, SRC, IFITM3, IL1B, CASP1, IL1RAP, GBP1, PDE4B, ISGF3G, SOS1, TNFRSF1B, RELA, CASP10, TXNRD1, SLAMF1, IER3, ENPEP, KLF6, DUSP5, LIF, CD69, TRIM21, ETS2, IL6, IL8, PLAUR
NETPATH IL 1 PATHWAY UPCCL20, FOSL1, NFKBIA, INHBA, CXCL2, TXNRD1, SOD2, PTX3, NFKB1, CXCL1, LIF, IL1A, CXCL5, IL6, PTGS2, IL8
NETPATH IL 4 PATHWAY DOWNCCL20, GADD45B, NFKBIA, IL6, PTGS2, NINJ1, CXCL2, IL8, TLR2
NCI IL23PATHWAYNFKB1, NFKBIA, IL6, IL1B, CXCL1, JAK2, IL18RAP
GERY CEBP TARGETSGADD45B, EREG, PLAT, RGS16, PEA15, S100A3, GCH1, SAT1, PTX3, CXCL1, JUNB, ANGPTL4, TNFAIP6, ATF3, DUSP1, PLAUR
NETPATH TNF ALPHA PATHWAY DOWNCCL20, IFIT5, HIF1A, CXCL3, NFKBIA, SDC4, CXCL2, IER3, NFKB1, CXCL1, PPP1R15A, JUNB, MAFF, DUSP2, IL6, TNFAIP3, PTGS2
NETPATH EGFR1 PATHWAY UPLIF, EREG, MT1G, SERPINB2, CXCL6, TGFA, EHD1, CXCL5, PTGS2, TNFAIP3, DUSP1, PLAUR, IER3
NCI TNFPATHWAYNFKB1, TNFAIP3, MAP4K4, CYLD, TNFRSF1B, RELA
NETPATH IL 5 PATHWAY UPRAB21, NFKB1, PLSCR1, DUSP5, IL8, IL1A, IER3, HIF1A, MYD88
NETPATH IL 1 PATHWAYNFKB1, NFKBIA, IL1RN, IL1B, IL1RAP, PELI1, IL1A, MYD88
NCI IL1PATHWAYNFKB1, IL1RN, IL1B, IL1RAP, IL1A, MYD88
NCI NFKAPPABCANONICALPATHWAYNFKB1, NFKBIA, TNFAIP3, CYLD, RELA
BIOCARTA IL10 PATHWAY
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
BIOCARTA STEM PATHWAY
BIOCARTA NFKB PATHWAY
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
BIOCARTA IL6 PATHWAY
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
KRASNOSELSKAYA ILF3 TARGETS UP
BIOCARTA RELA PATHWAY
RASHI RESPONSE TO IONIZING RADIATION 2
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
AMIT EGF RESPONSE 40 HELA
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
KIM WT1 TARGETS 12HR DN
NETPATH IL 7 PATHWAY UP
AMIT EGF RESPONSE 480 HELA
NCI ET EGFRPATHWAY
MITSIADES RESPONSE TO APLIDIN UP
KEGG COMPLEMENT AND COAGULATION CASCADES
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
NCI DISSOLUTION OF FIBRIN CLOT
TRAYNOR RETT SYNDROM UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
CONRAD GERMLINE STEM CELL
LENAOUR DENDRITIC CELL MATURATION DN
HINATA NFKB TARGETS KERATINOCYTE UP
DORN ADENOVIRUS INFECTION 48HR DN
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
MARKEY RB1 ACUTE LOF UP
AMIT SERUM RESPONSE 60 MCF10A
DORSEY GAB2 TARGETS
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
HAN SATB1 TARGETS DN
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
LIU VAV3 PROSTATE CARCINOGENESIS UP
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
DEBOSSCHER NFKB TARGETS REPRESSED BY GLUCOCORTICOIDS
AMIT EGF RESPONSE 120 HELA
BIOCARTA RANKL PATHWAY
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
MCLACHLAN DENTAL CARIES UP
PODAR RESPONSE TO ADAPHOSTIN UP
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
CORUM ABIN2-NFKB1-MAP3K8 COMPLEX
KYNG DNA DAMAGE UP
LEE LIVER CANCER E2F1 UP
NCI VIRAL MRNA TRANSLATIONRPL10, RPS15A, RPS11, RPS18, RPLP1, RPL23A, RPL38, RPS3A, RPS10, RPS14, RPS21, RPS5, RPS16, RPL13, RPS23, RPS19, RPS12, RPL30, RPS13, RPL9, RPS29, RPS2, RPL39, RPS24, RPS27, RPS20, RPL41
REACTOME VIRAL MRNA TRANSLATION
WANG SMARCE1 TARGETS DN
HELLER SILENCED BY METHYLATION UP
KEGG CELL ADHESION MOLECULES CAMS
NCI EUKARYOTIC TRANSLATION TERMINATIONRPL10, RPS15A, RPS11, RPS18, RPLP1, RPL23A, RPL38, RPS3A, RPS10, RPS14, RPS21, RPS5, RPS16, RPL13, RPS23, RPS19, RPS12, RPL30, RPS13, RPL9, RPS29, RPS2, RPL39, RPS24, RPS27, RPS20, RPL41
NCI PEPTIDE CHAIN ELONGATIONRPL10, RPS15A, RPS11, RPS18, RPLP1, RPL23A, RPL38, RPS3A, RPS10, RPS14, RPS21, RPS5, RPS16, RPL13, RPS23, RPS19, RPS12, EEF1A1, RPL30, RPL9, RPS13, RPS29, RPS2, RPL39, RPS24, RPS27, RPS20, RPL41
BOWIE RESPONSE TO TAMOXIFEN
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
NETPATH TGFBETA RECEPTOR PATHWAY DOWN
VANTVEER BREAST CANCER ESR1 DN
DORN ADENOVIRUS INFECTION 24HR DN
PUIFFE INVASION INHIBITED BY ASCITES DN
FALVELLA SMOKERS WITH LUNG CANCER
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
NCI P53DOWNSTREAMPATHWAY
NCI IL12 2PATHWAY
TIAN TNF SIGNALING VIA NFKB
HUMMEL BURKITTS LYMPHOMA DN
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
BIOCARTA IL3 PATHWAY
GOLUB ALL VS AML DN
KEGG APOPTOSIS
HOFMANN MYELODYSPLASTIC SYNDROM LOW RISK DN
HUANG DASATINIB RESISTANCE UP
HINATA NFKB TARGETS FIBROBLAST UP
HOSHIDA LIVER CANCER SURVIVAL UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
MISSIAGLIA REGULATED BY METHYLATION UP
ZHANG INTERFERON RESPONSE
BROWNE HCMV INFECTION 12HR UP
KEGG ASTHMA
SESTO RESPONSE TO UV C1
CROONQUIST STROMAL STIMULATION UP
BLUM RESPONSE TO SALIRASIB UP
SIMBULAN UV RESPONSE NORMAL UP
KIM LRRC3B TARGETS
HORIUCHI WTAP TARGETS UP
NCI CMYB PATHWAY
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN UP
DORN ADENOVIRUS INFECTION 12HR UP
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX 9
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS UP
NCI LYSOPHOSPHOLIPID PATHWAY
BIOCARTA TH1TH2 PATHWAY
KEGG JAK STAT SIGNALING PATHWAY
TURASHVILI BREAST DUCTAL CARCINOMA VS DUCTAL NORMAL DN
DER IFN BETA RESPONSE UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
NCI REGULATED PROTEOLYSIS OF P75NTR
DIRMEIER LMP1 RESPONSE LATE UP
SEIKE LUNG CANCER POOR SURVIVAL
BIOCARTA CYTOKINE PATHWAY
GILDEA METASTASIS
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
HOUSTIS ROS
BASSO CD40 SIGNALING UP
BIOCARTA NTHI PATHWAY
MARZEC IL2 SIGNALING UP
NAGASHIMA NRG1 SIGNALING UP
CHIBA RESPONSE TO TSA DN
ENK UV RESPONSE EPIDERMIS DN
ZERBINI RESPONSE TO SULINDAC UP
WANG ESOPHAGUS CANCER VS NORMAL UP
FRIDMAN SENESCENCE UP
CROMER TUMORIGENESIS UP
NCI PTP1BPATHWAY
WU HBX TARGETS 2 DN
NETPATH B CELL RECEPTOR PATHWAY UP
MAHADEVAN RESPONSE TO MP470 UP
CORRE MULTIPLE MYELOMA UP
KEGG PROSTATE CANCER
FERRARI RESPONSE TO FENRETINIDE UP
BIOCARTA TID PATHWAY
KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION DN
NETPATH WNT PATHWAY DOWN
SANA RESPONSE TO IFNG UP
KEGG LEISHMANIA INFECTION
SCHEIDEREIT IKK TARGETS
NCI NF KB IS ACTIVATED AND SIGNALS SURVIVAL
REACTOME PEPTIDE CHAIN ELONGATION
WU HBX TARGETS 1 UP
CHEN HOXA5 TARGETS 9HR UP
BIOCARTA DEATH PATHWAY
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
MURAKAMI UV RESPONSE 6HR UP
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
MOSERLE IFNA RESPONSE
FOSTER INFLAMMATORY RESPONSE LPS UP
WANG METHYLATED IN BREAST CANCER
BIOCARTA ASBCELL PATHWAY
RODWELL AGING KIDNEY UP
SENESE HDAC1 TARGETS UP
LIU TARGETS OF VMYB VS CMYB DN
KIM WT1 TARGETS UP
REACTOME P75NTR SIGNALS VIA NFKB
ONDER CDH1 TARGETS 1 DN
KEGG CYTOSOLIC DNA SENSING PATHWAY
MORI IMMATURE B LYMPHOCYTE UP
DORSAM HOXA9 TARGETS DN
ELVIDGE HYPOXIA BY DMOG UP
AMIT EGF RESPONSE 120 MCF10A
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
SMID BREAST CANCER RELAPSE IN BONE DN
PRAMOONJAGO SOX4 TARGETS UP
KOBAYASHI RESPONSE TO ROMIDEPSIN
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
GENTILE UV RESPONSE CLUSTER D2
BIOCARTA PML PATHWAY
ZHU CMV 24 HR UP
BOYAULT LIVER CANCER SUBCLASS G5 DN
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION A
HOFMANN CELL LYMPHOMA DN
MORI LARGE PRE BII LYMPHOCYTE DN
ELVIDGE HYPOXIA UP
NETPATH TGFBETA RECEPTOR PATHWAY UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
SESTO RESPONSE TO UV C2
BROWNE INTERFERON RESPONSIVE GENES
NCI IL6 7PATHWAY
ROETH TERT TARGETS UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
FRIDMAN IMMORTALIZATION DN
NCI TRAIL SIGNALING
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
DAZARD UV RESPONSE CLUSTER G3
XU HGF TARGETS INDUCED BY AKT1 48HR UP
VART KSHV INFECTION ANGIOGENIC MARKERS UP
OSADA ASCL1 TARGETS DN
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
TSAI RESPONSE TO IONIZING RADIATION
DELYS THYROID CANCER UP
CORUM RIBOSOME CYTOPLASMICRPL10, RPS15A, RPS11, RPS18, RPLP1, RPL23A, RPL38, RPS3A, RPS10, RPS14, RPS21, RPS5, RPS16, RPL13, RPS23, RPS19, RPS12, RPL30, RPL9, RPS13, RPS29, RPS2, RPL39, RPS24, RPS27, RPS20, RPL41
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
AMIT SERUM RESPONSE 240 MCF10A
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
ZHAN V1 LATE DIFFERENTIATION GENES UP
BIOCARTA FREE PATHWAY
NCI NFAT TFPATHWAY
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS RED UP
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
WINTER HYPOXIA METAGENE
DAZARD RESPONSE TO UV NHEK UP
NETPATH TNF ALPHA PATHWAY
NEWMAN ERCC6 TARGETS UP
ISHIKAWA STING SIGNALING
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
TAVOR CEBPA TARGETS UP
FOSTER INFLAMMATORY RESPONSE LPS DN
GAURNIER PSMD4 TARGETS
BIOCARTA FIBRINOLYSIS PATHWAY
GRANDVAUX IFN RESPONSE NOT VIA IRF3
OSAWA TNF TARGETS
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
MARKEY RB1 CHRONIC LOF DN
NCI AMB2 NEUTROPHILS PATHWAY
NOJIMA SFRP2 TARGETS DN
KEGG T CELL RECEPTOR SIGNALING PATHWAY
AMIT SERUM RESPONSE 120 MCF10A
BROWNE HCMV INFECTION 2HR UP
LEE LIVER CANCER MYC E2F1 UP
SESTO RESPONSE TO UV C3
KEGG RIBOSOME
REACTOME DEATH RECEPTOR SIGNALLING
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX RPL6 RPL30 RPS13 CHUK DDX3X NFKB2 NFKBIB REL IKBKG NFKB1 MAP3K8 RELB GLG1 NFKBIA RELA TNIP2 GTF2I
ZHOU INFLAMMATORY RESPONSE FIMA UP
REACTOME VIRAL DSRNA TLR3 TRIF COMPLEX ACTIVATES RIP1
SENESE HDAC2 TARGETS UP
ZHU CMV ALL UP
ROZANOV MMP14 TARGETS UP
GRUETZMANN PANCREATIC CANCER UP
OKUMURA INFLAMMATORY RESPONSE LPS
NATSUME RESPONSE TO INTERFERON BETA UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
KEGG TYPE I DIABETES MELLITUS
AMIT DELAYED EARLY GENES
AMIT EGF RESPONSE 60 MCF10A
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
NCI FORMATION OF A POOL OF FREE 40S SUBUNITSRPL10, RPS15A, RPS11, RPS18, RPLP1, RPL23A, RPL38, RPS3A, RPS10, RPS14, RPS21, RPS5, RPS16, RPL13, RPS23, RPS19, RPS12, RPL30, RPS13, RPL9, RPS29, RPS2, RPL39, RPS24, RPS27, RPS20, RPL41
CHEN LVAD SUPPORT OF FAILING HEART DN
RICKMAN TUMOR DIFFERENTIATED WELL VS MODERATELY DN
DORN ADENOVIRUS INFECTION 32HR DN
LEE LIVER CANCER MYC TGFA UP
HALMOS CEBPA TARGETS UP
WU CELL MIGRATION
CHANDRAN METASTASIS DN
WALLACE PROSTATE CANCER RACE UP
SAGIV CD24 TARGETS DN
WIELAND UP BY HBV INFECTION
MAHADEVAN RESPONSE TO MP470 DN
DORN ADENOVIRUS INFECTION 12HR DN
UROSEVIC RESPONSE TO IMIQUIMOD
LU TUMOR ANGIOGENESIS UP
NETPATH KIT RECEPTOR PATHWAY UP
HARRIS HYPOXIA
CORUM CHUK-NFKB2-REL-IKBKG-SPAG9-NFKB1-NFKBIE-COPB2-TNIP1-NFKBIA-RELA-TNIP2 COMPLEX
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
ENK UV RESPONSE KERATINOCYTE UP
NETPATH B CELL RECEPTOR PATHWAY DOWN
XU RESPONSE TO TRETINOIN AND NSC682994 UP
SOUCEK MYC TARGETS
BIOCARTA IL5 PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
KEGG B CELL RECEPTOR SIGNALING PATHWAY
IZADPANAH STEM CELL ADIPOSE VS BONE UP
NCI DOWNSTREAM TCR SIGNALING
CORUM ITGA2B-ITGB3-CD47-SRC COMPLEX
ZHAN MULTIPLE MYELOMA LB DN
MIZUKAMI HYPOXIA DN
KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
BILD HRAS ONCOGENIC SIGNATURE
ZHAN MULTIPLE MYELOMA SPIKED
NETPATH IL 3 PATHWAY UP
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
NETPATH IL 6 PATHWAY UPMAFF, GADD45B, CXCL1, PIM2, JUNB, CEBPB, MAP3K8, NMI
BIOCARTA RNA PATHWAY
DER IFN ALPHA RESPONSE UP
MENSE HYPOXIA UP
BERENJENO TRANSFORMED BY RHOA FOREVER DN
REACTOME NF KB IS ACTIVATED AND SIGNALS SURVIVAL
DAZARD UV RESPONSE CLUSTER G2
EINAV INTERFERON SIGNATURE IN CANCER
MCLACHLAN DENTAL CARIES DN
KEGG ALLOGRAFT REJECTION
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
ZHU CMV 8 HR UP
BIERIE INFLAMMATORY RESPONSE TGFB1
BIOCARTA INFLAM PATHWAY
SANA TNF SIGNALING UP
NCI IL27PATHWAY
SENESE HDAC1 AND HDAC2 TARGETS UP
ONDER CDH1 TARGETS 2 DN
AMIT EGF RESPONSE 240 HELA
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
SENESE HDAC3 TARGETS UP
BUDHU LIVER CANCER METASTASIS UP
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN
STREICHER LSM1 TARGETS DN
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
KOBAYASHI EGFR SIGNALING 6HR DN
JISON SICKLE CELL DISEASE UP
XU HGF SIGNALING NOT VIA AKT1 48HR UP
DASU IL6 SIGNALING UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
REACTOME FORMATION OF A POOL OF FREE 40S SUBUNITS
BOHN PRIMARY IMMUNODEFICIENCY SYNDROM DN
NCI PDGFRBPATHWAY
ZUCCHI METASTASIS DN
BRUECKNER TARGETS OF MIRLET7A3 UP
SMID BREAST CANCER BASAL UP
YAMASHITA METHYLATED IN PROSTATE CANCER
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
pseudomonas aeruginosa fdr440listeria monocytogenesescherichia coliGeneSet Name
0.00318 0.00123 0.00001NETPATH_TNF_ALPHA_PATHWAY_UP
0.00843 0.00068 0.00000NETPATH_IL_2_PATHWAY_UP
0.00000 0.00000 0.00000NETPATH_IL_1_PATHWAY_UP
0.00000 0.00001 0.00000NETPATH_IL_4_PATHWAY_DOWN
0.01471 0.00100 0.00000NCI_IL23PATHWAY
0.00131 0.00163 0.01389GERY_CEBP_TARGETS
0.01426 0.00007 0.00002NETPATH_TNF_ALPHA_PATHWAY_DOWN
0.00005 0.03270 0.00008NETPATH_EGFR1_PATHWAY_UP
0.03239 0.03361 0.00010NCI_TNFPATHWAY
0.00726 0.00007 0.00001NETPATH_IL_5_PATHWAY_UP
0.00311 0.00142 0.00003NETPATH_IL_1_PATHWAY
0.07208 0.00886 0.00686NCI_IL1PATHWAY
0.01645 0.01014 0.00009NCI_NFKAPPABCANONICALPATHWAY
0.01645 0.00014 0.00002BIOCARTA_IL10_PATHWAY
0.01700 0.00023 0.00000GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.01042 0.05829 0.00008BIOCARTA_STEM_PATHWAY
0.00100 0.08391 0.00000BIOCARTA_NFKB_PATHWAY
0.00044 0.00046 0.00000MAHAJAN_RESPONSE_TO_IL1A_UP
0.01567 0.01186 0.00000WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.09012 0.05350 0.02803BIOCARTA_IL6_PATHWAY
0.00000 0.00437 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.06380 0.00776 0.00000BIOCARTA_IL1R_PATHWAY
0.11846 0.00001 0.00000KRASNOSELSKAYA_ILF3_TARGETS_UP
0.00063 0.07380 0.00033BIOCARTA_RELA_PATHWAY
0.00000 0.04054 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00347 0.00043 0.00127LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.00064 0.01417 0.00026IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.15015 0.00068 0.00000AMIT_EGF_RESPONSE_40_HELA
0.03539 0.00007 0.00001BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.13226 0.10987 0.06575KIM_WT1_TARGETS_12HR_DN
0.00003 0.09197 0.00000NETPATH_IL_7_PATHWAY_UP
0.00520 0.14707 0.01590AMIT_EGF_RESPONSE_480_HELA
0.11621 0.06852 0.19650NCI_ET_EGFRPATHWAY
0.01817 0.00418 0.02480MITSIADES_RESPONSE_TO_APLIDIN_UP
0.08530 0.00615 0.00386KEGG_COMPLEMENT_AND_COAGULATION_CASCADES
0.00052 0.00000 0.00000THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.03838 0.17554 0.12964NCI_DISSOLUTION_OF_FIBRIN_CLOT
0.13740 0.00878 0.00022TRAYNOR_RETT_SYNDROM_UP
0.11741 0.00008 0.00220TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.08773 0.03560 0.17103CONRAD_GERMLINE_STEM_CELL
0.10124 0.00005 0.02437LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.00000 0.00001 0.00000HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.00037 0.00579 0.00089DORN_ADENOVIRUS_INFECTION_48HR_DN
0.05096 0.12454 0.00331KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.01820 0.00004 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.01060 0.02234 0.00109AMIT_SERUM_RESPONSE_60_MCF10A
0.03208 0.08448 0.00032DORSEY_GAB2_TARGETS
0.02348 0.03942 0.01809COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.04178 0.00178 0.02827GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.00625 0.00346 0.01800HAN_SATB1_TARGETS_DN
0.00883 0.00003 0.10906RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.00848 0.01016 0.00647LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.05479 0.00001 0.00000SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.02769 0.00000 0.00155GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.02560 0.09424 0.02153DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.00068 0.02592 0.00046AMIT_EGF_RESPONSE_120_HELA
0.01277 0.17317 0.05932BIOCARTA_RANKL_PATHWAY
0.01555 0.01810 0.00949FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.00001 0.00000 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.13382 0.00004 0.01026PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.09246 0.01078 0.05575SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.07172 0.17672 0.06859CORUM_ABIN2-NFKB1-MAP3K8_COMPLEX
0.00132 0.04501 0.03420KYNG_DNA_DAMAGE_UP
0.16834 0.02021 0.00843LEE_LIVER_CANCER_E2F1_UP
0.00000 0.00228 0.01461NCI_VIRAL_MRNA_TRANSLATION
0.00000 0.00240 0.01642REACTOME_VIRAL_MRNA_TRANSLATION
0.01270 0.04978 0.06905WANG_SMARCE1_TARGETS_DN
0.01964 0.07324 0.00002HELLER_SILENCED_BY_METHYLATION_UP
0.06288 0.14244 0.00444KEGG_CELL_ADHESION_MOLECULES_CAMS
0.00000 0.00064 0.01385NCI_EUKARYOTIC_TRANSLATION_TERMINATION
0.00000 0.00108 0.00472NCI_PEPTIDE_CHAIN_ELONGATION
0.04904 0.00001 0.00000BOWIE_RESPONSE_TO_TAMOXIFEN
0.00710 0.12803 0.00006SMID_BREAST_CANCER_LUMINAL_B_DN
0.00027 0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.12159 0.05923 0.06355NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.06647 0.02711 0.00141VANTVEER_BREAST_CANCER_ESR1_DN
0.00130 0.00441 0.00667DORN_ADENOVIRUS_INFECTION_24HR_DN
0.14437 0.00272 0.06075PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.00018 0.01169 0.00399FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.00218 0.00000 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.04896 0.00001 0.00002BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.02164 0.14599 0.00831NCI_P53DOWNSTREAMPATHWAY
0.06732 0.04187 0.00000NCI_IL12_2PATHWAY
0.00000 0.00054 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.01003 0.17259 0.00005HUMMEL_BURKITTS_LYMPHOMA_DN
0.09337 0.02242 0.00000KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.14823 0.09618 0.18796BIOCARTA_IL3_PATHWAY
0.00002 0.01375 0.11780GOLUB_ALL_VS_AML_DN
0.09557 0.08467 0.00000KEGG_APOPTOSIS
0.06924 0.02089 0.11170HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.09974 0.07424 0.00046HUANG_DASATINIB_RESISTANCE_UP
0.00000 0.00031 0.00000HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.06291 0.06841 0.00099HOSHIDA_LIVER_CANCER_SURVIVAL_UP
0.00001 0.00002 0.00000CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00000 0.00001 0.00000MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.00495 0.00000 0.00000ZHANG_INTERFERON_RESPONSE
0.09407 0.12016 0.01673BROWNE_HCMV_INFECTION_12HR_UP
0.02296 0.00022 0.01109KEGG_ASTHMA
0.00240 0.00001 0.00038SESTO_RESPONSE_TO_UV_C1
0.00017 0.05925 0.00003CROONQUIST_STROMAL_STIMULATION_UP
0.00885 0.03125 0.11927BLUM_RESPONSE_TO_SALIRASIB_UP
0.01311 0.04183 0.01024SIMBULAN_UV_RESPONSE_NORMAL_UP
0.02984 0.00001 0.00004KIM_LRRC3B_TARGETS
0.00881 0.01805 0.00002HORIUCHI_WTAP_TARGETS_UP
0.06914 0.10706 0.13033NCI_CMYB_PATHWAY
0.00768 0.07255 0.00057ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.04477 0.02117 0.04767DORN_ADENOVIRUS_INFECTION_12HR_UP
0.14319 0.09665 0.19679CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_9
0.08542 0.07558 0.00220CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.19187 0.09180 0.01449DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.06542 0.00321 0.09447NCI_LYSOPHOSPHOLIPID_PATHWAY
0.00729 0.02563 0.00439BIOCARTA_TH1TH2_PATHWAY
0.15521 0.17844 0.00009KEGG_JAK_STAT_SIGNALING_PATHWAY
0.00130 0.12603 0.00475TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.00222 0.00000 0.00000DER_IFN_BETA_RESPONSE_UP
0.00448 0.00000 0.00002DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.19099 0.17033 0.01182NCI_REGULATED_PROTEOLYSIS_OF_P75NTR
0.00027 0.12444 0.00000DIRMEIER_LMP1_RESPONSE_LATE_UP
0.00573 0.00438 0.00018SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.00347 0.02298 0.00002BIOCARTA_CYTOKINE_PATHWAY
0.03836 0.14957 0.10376GILDEA_METASTASIS
0.13279 0.00061 0.10451TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.13513 0.01226 0.11100HOUSTIS_ROS
0.00000 0.00020 0.00000BASSO_CD40_SIGNALING_UP
0.00021 0.03739 0.00024BIOCARTA_NTHI_PATHWAY
0.01502 0.00507 0.00002MARZEC_IL2_SIGNALING_UP
0.00002 0.00045 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.01274 0.04833 0.00034CHIBA_RESPONSE_TO_TSA_DN
0.02173 0.00904 0.02283ENK_UV_RESPONSE_EPIDERMIS_DN
0.03840 0.05033 0.02814ZERBINI_RESPONSE_TO_SULINDAC_UP
0.00878 0.17037 0.00496WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.00103 0.15020 0.00001FRIDMAN_SENESCENCE_UP
0.01404 0.01616 0.00002CROMER_TUMORIGENESIS_UP
0.11264 0.07255 0.00089NCI_PTP1BPATHWAY
0.19091 0.00791 0.00219WU_HBX_TARGETS_2_DN
0.17531 0.03363 0.00228NETPATH_B_CELL_RECEPTOR_PATHWAY_UP
0.00002 0.00004 0.00000MAHADEVAN_RESPONSE_TO_MP470_UP
0.02454 0.10145 0.00171CORRE_MULTIPLE_MYELOMA_UP
0.07547 0.05363 0.19746KEGG_PROSTATE_CANCER
0.00002 0.06128 0.00016FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.00010 0.07253 0.00058BIOCARTA_TID_PATHWAY
0.03234 0.05669 0.00000KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.02710 0.07491 0.19702SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN
0.07767 0.13456 0.02713NETPATH_WNT_PATHWAY_DOWN
0.04172 0.00000 0.00000SANA_RESPONSE_TO_IFNG_UP
0.00027 0.00055 0.00028KEGG_LEISHMANIA_INFECTION
0.00766 0.12320 0.00617SCHEIDEREIT_IKK_TARGETS
0.05004 0.07063 0.00474NCI_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.00000 0.00119 0.00626REACTOME_PEPTIDE_CHAIN_ELONGATION
0.02293 0.08533 0.00099WU_HBX_TARGETS_1_UP
0.00550 0.00000 0.00050CHEN_HOXA5_TARGETS_9HR_UP
0.00012 0.12229 0.00002BIOCARTA_DEATH_PATHWAY
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00002 0.00097 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.03175 0.00060 0.08735CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.15080 0.07302 0.09309MURAKAMI_UV_RESPONSE_6HR_UP
0.06733 0.00000 0.01185BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.00512 0.00000 0.00000MOSERLE_IFNA_RESPONSE
0.09494 0.00000 0.00011FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.06554 0.17968 0.00010WANG_METHYLATED_IN_BREAST_CANCER
0.00861 0.00550 0.00194BIOCARTA_ASBCELL_PATHWAY
0.06598 0.11822 0.15541RODWELL_AGING_KIDNEY_UP
0.00013 0.00009 0.00079SENESE_HDAC1_TARGETS_UP
0.08512 0.05670 0.01565LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.00002 0.01564 0.00002KIM_WT1_TARGETS_UP
0.01970 0.02184 0.00047REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.00709 0.00003 0.00021ONDER_CDH1_TARGETS_1_DN
0.01678 0.00588 0.00000KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.03187 0.00266 0.08736MORI_IMMATURE_B_LYMPHOCYTE_UP
0.02759 0.00116 0.11054DORSAM_HOXA9_TARGETS_DN
0.15685 0.00142 0.01098ELVIDGE_HYPOXIA_BY_DMOG_UP
0.00020 0.00423 0.00004AMIT_EGF_RESPONSE_120_MCF10A
0.00011 0.00001 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.01010 0.17026 0.01277SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
0.00044 0.01526 0.00005PRAMOONJAGO_SOX4_TARGETS_UP
0.13806 0.15522 0.05937KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.06556 0.00887 0.02690PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.09404 0.15424 0.12081GENTILE_UV_RESPONSE_CLUSTER_D2
0.00518 0.00624 0.01149BIOCARTA_PML_PATHWAY
0.08903 0.00001 0.00000ZHU_CMV_24_HR_UP
0.02290 0.00070 0.00515BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
0.00068 0.00001 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.05310 0.09679 0.00011TENEDINI_MEGAKARYOCYTE_MARKERS
0.00003 0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.01001 0.09034 0.06043HOFMANN_CELL_LYMPHOMA_DN
0.05973 0.16365 0.19860MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.16459 0.00023 0.01124ELVIDGE_HYPOXIA_UP
0.00516 0.07219 0.04532NETPATH_TGFBETA_RECEPTOR_PATHWAY_UP
0.06558 0.15820 0.03327YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.01720 0.00026 0.01450SESTO_RESPONSE_TO_UV_C2
0.00002 0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.14730 0.03989 0.00785NCI_IL6_7PATHWAY
0.10447 0.00096 0.00141ROETH_TERT_TARGETS_UP
0.06129 0.00030 0.00807TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.05960 0.16402 0.00651FRIDMAN_IMMORTALIZATION_DN
0.01306 0.09568 0.02189NCI_TRAIL__SIGNALING
0.00034 0.00736 0.00000KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.01564 0.00837 0.00510DAZARD_UV_RESPONSE_CLUSTER_G3
0.00999 0.04325 0.00136XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.08419 0.01472 0.00000VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.11392 0.04416 0.00002OSADA_ASCL1_TARGETS_DN
0.00021 0.00000 0.00000NUYTTEN_EZH2_TARGETS_UP
0.00513 0.01422 0.00000DUTTA_APOPTOSIS_VIA_NFKB
0.04793 0.13958 0.00126TSAI_RESPONSE_TO_IONIZING_RADIATION
0.00736 0.05915 0.00200DELYS_THYROID_CANCER_UP
0.00000 0.00123 0.00802CORUM_RIBOSOME_CYTOPLASMIC
0.00002 0.00199 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.00011 0.00068 0.00000DER_IFN_GAMMA_RESPONSE_UP
0.00002 0.00207 0.00128AMIT_SERUM_RESPONSE_240_MCF10A
0.03514 0.00181 0.00010KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.06522 0.00000 0.00000BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.05368 0.02300 0.00777ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.04271 0.08760 0.00130BIOCARTA_FREE_PATHWAY
0.04224 0.05773 0.00004NCI_NFAT_TFPATHWAY
0.00010 0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00194 0.00011 0.00000ONDER_CDH1_TARGETS_3_DN
0.07493 0.02791 0.11790GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.00016 0.16188 0.00004HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.05763 0.00001 0.04537NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.01078 0.01127 0.00438NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00135 0.00186 0.02164WINTER_HYPOXIA_METAGENE
0.10778 0.01225 0.00002DAZARD_RESPONSE_TO_UV_NHEK_UP
0.03241 0.08032 0.00219NETPATH_TNF_ALPHA_PATHWAY
0.03524 0.09674 0.00184NEWMAN_ERCC6_TARGETS_UP
0.06552 0.02022 0.00301ISHIKAWA_STING_SIGNALING
0.12253 0.00001 0.10160GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.08516 0.00125 0.00020TAVOR_CEBPA_TARGETS_UP
0.00037 0.00001 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00002 0.00001 0.00000GAURNIER_PSMD4_TARGETS
0.01388 0.07984 0.00489BIOCARTA_FIBRINOLYSIS_PATHWAY
0.04085 0.00061 0.00002GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.00149 0.05254 0.00142OSAWA_TNF_TARGETS
0.01084 0.03199 0.00071SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.05680 0.00005 0.09710MARKEY_RB1_CHRONIC_LOF_DN
0.00315 0.18259 0.00044NCI_AMB2_NEUTROPHILS_PATHWAY
0.16491 0.02237 0.00025NOJIMA_SFRP2_TARGETS_DN
0.14892 0.14664 0.10958KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.02960 0.00040 0.00011AMIT_SERUM_RESPONSE_120_MCF10A
0.00002 0.02059 0.00014BROWNE_HCMV_INFECTION_2HR_UP
0.11981 0.02477 0.08000LEE_LIVER_CANCER_MYC_E2F1_UP
0.02538 0.00002 0.00001SESTO_RESPONSE_TO_UV_C3
0.00000 0.00580 0.11047KEGG_RIBOSOME
0.00028 0.07287 0.00004REACTOME_DEATH_RECEPTOR_SIGNALLING
0.00007 0.00027 0.00000GEISS_RESPONSE_TO_DSRNA_UP
0.03950 0.00032 0.00000GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.00499 0.07166 0.00653SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.00282 0.16339 0.00003CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_RPL6_RPL30_RPS13_CHUK_DDX3X_NFKB2_NFKBIB_REL_IKBKG_NFKB1_MAP3K8_RELB_GLG1_NFKBIA_RELA_TNIP2__GTF2I
0.00013 0.00125 0.00000ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.00313 0.18525 0.00018REACTOME_VIRAL_DSRNA_TLR3_TRIF_COMPLEX_ACTIVATES_RIP1
0.00858 0.00878 0.00293SENESE_HDAC2_TARGETS_UP
0.02420 0.00000 0.00000ZHU_CMV_ALL_UP
0.13315 0.05511 0.02679ROZANOV_MMP14_TARGETS_UP
0.08530 0.00031 0.02087GRUETZMANN_PANCREATIC_CANCER_UP
0.01148 0.00777 0.00002OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.10120 0.13098 0.06156NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.00243 0.02848 0.00010LEE_LIVER_CANCER_HEPATOBLAST
0.00002 0.00001 0.00003NAGASHIMA_EGF_SIGNALING_UP
0.11089 0.00007 0.00002KEGG_TYPE_I_DIABETES_MELLITUS
0.04277 0.00200 0.00082AMIT_DELAYED_EARLY_GENES
0.00027 0.01523 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.00195 0.02915 0.00000KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.00010 0.00001 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.01991 0.00015 0.01400SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00000 0.00061 0.00702NCI_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS
0.15184 0.01521 0.19530CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.00037 0.02472 0.01726RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.00021 0.01095 0.00003DORN_ADENOVIRUS_INFECTION_32HR_DN
0.06140 0.00938 0.07586LEE_LIVER_CANCER_MYC_TGFA_UP
0.00031 0.01542 0.00001HALMOS_CEBPA_TARGETS_UP
0.11574 0.00267 0.00033WU_CELL_MIGRATION
0.06578 0.06255 0.00634CHANDRAN_METASTASIS_DN
0.15257 0.00031 0.00004WALLACE_PROSTATE_CANCER_RACE_UP
0.00091 0.09742 0.00010SAGIV_CD24_TARGETS_DN
0.08331 0.00000 0.00002WIELAND_UP_BY_HBV_INFECTION
0.02760 0.01146 0.00317MAHADEVAN_RESPONSE_TO_MP470_DN
0.00157 0.00201 0.00337DORN_ADENOVIRUS_INFECTION_12HR_DN
0.00512 0.00008 0.00000UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.15098 0.02679 0.01099LU_TUMOR_ANGIOGENESIS_UP
0.18259 0.05671 0.00023NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00003 0.00000 0.00034HARRIS_HYPOXIA
0.00017 0.05617 0.00004CORUM_CHUK-NFKB2-REL-IKBKG-SPAG9-NFKB1-NFKBIE-COPB2-TNIP1-NFKBIA-RELA-TNIP2_COMPLEX
0.01727 0.04308 0.00007KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.00219 0.00904 0.01710ENK_UV_RESPONSE_KERATINOCYTE_UP
0.05263 0.00901 0.04764NETPATH_B_CELL_RECEPTOR_PATHWAY_DOWN
0.02705 0.00143 0.00009XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
0.02994 0.09270 0.00037SOUCEK_MYC_TARGETS
0.14847 0.01405 0.01109BIOCARTA_IL5_PATHWAY
0.06809 0.00142 0.05842TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.19658 0.12277 0.09546KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.00336 0.00386 0.00049IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.08727 0.04507 0.03029NCI_DOWNSTREAM_TCR_SIGNALING
0.14322 0.17851 0.10198CORUM_ITGA2B-ITGB3-CD47-SRC_COMPLEX
0.08690 0.00177 0.00002ZHAN_MULTIPLE_MYELOMA_LB_DN
0.09212 0.14691 0.03300MIZUKAMI_HYPOXIA_DN
0.03074 0.02896 0.00438KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.15531 0.00105 0.00249SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.00028 0.00000 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.08608 0.14239 0.03264ZHAN_MULTIPLE_MYELOMA_SPIKED
0.15088 0.00553 0.00000NETPATH_IL_3_PATHWAY_UP
0.00005 0.00001 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.00085 0.00016 0.00003DAUER_STAT3_TARGETS_UP
0.03716 0.00233 0.00000NETPATH_IL_6_PATHWAY_UP
0.01082 0.03822 0.00522BIOCARTA_RNA_PATHWAY
0.00312 0.00000 0.00000DER_IFN_ALPHA_RESPONSE_UP
0.05632 0.01410 0.09188MENSE_HYPOXIA_UP
0.11486 0.03353 0.00016BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.04950 0.06528 0.00247REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.00228 0.04745 0.00004DAZARD_UV_RESPONSE_CLUSTER_G2
0.03104 0.00000 0.00000EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.00017 0.00000 0.00002MCLACHLAN_DENTAL_CARIES_DN
0.05771 0.00001 0.00000KEGG_ALLOGRAFT_REJECTION
0.00000 0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.06119 0.00000 0.00000ZHU_CMV_8_HR_UP
0.00969 0.05971 0.01522BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.00030 0.00012 0.00000BIOCARTA_INFLAM_PATHWAY
0.00000 0.00000 0.00000SANA_TNF_SIGNALING_UP
0.10440 0.04900 0.00000NCI_IL27PATHWAY
0.00002 0.00023 0.00002SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00005 0.00554 0.00002ONDER_CDH1_TARGETS_2_DN
0.01646 0.00272 0.00023AMIT_EGF_RESPONSE_240_HELA
0.00011 0.00000 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.06875 0.12933 0.03679SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.01005 0.00256 0.00076SENESE_HDAC3_TARGETS_UP
0.06612 0.01011 0.00702BUDHU_LIVER_CANCER_METASTASIS_UP
0.11601 0.00737 0.00371CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
0.00029 0.02242 0.07719STREICHER_LSM1_TARGETS_DN
0.02749 0.00007 0.00044UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00558 0.00146 0.00132XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.00005 0.01417 0.00015KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.19067 0.00000 0.00023JISON_SICKLE_CELL_DISEASE_UP
0.00146 0.00850 0.05998XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.00711 0.00595 0.00015DASU_IL6_SIGNALING_UP
0.00000 0.00001 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00000 0.00078 0.01101REACTOME_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS
0.18397 0.11830 0.03648BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.16441 0.02074 0.12159NCI_PDGFRBPATHWAY
0.00002 0.00518 0.00000ZUCCHI_METASTASIS_DN
0.12920 0.00484 0.11099BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.03515 0.14974 0.00694SMID_BREAST_CANCER_BASAL_UP
0.03555 0.09035 0.00355YAMASHITA_METHYLATED_IN_PROSTATE_CANCER